Endo USA, Inc.

Form 483 issued January 17, 2025 · Cranbury, New Jersey

Inspection
Jan 7 – Jan 17, 2025
Investigator
Ankur C. Patel
Observations
9
Pages
13
FEI number
2243842

In short: On January 17, 2025, FDA issued a Form 483 with 9 observations to Endo USA, Inc. in Cranbury, New Jersey (FEI 2243842) after an inspection that ran Jan 7 – Jan 17, 2025. The investigator was Ankur C. Patel. Most observations concern laboratory controls; the most-cited regulation is 21 CFR 211.160 (general requirements).

At a glance

Observations span 1 system, led by laboratory controls.

Laboratory controls1
Other1

Most cited: 21 CFR 211.160(b) (1×)

What FDA observed

Preview: the opening words of each observation
  1. 01

    Observation 1: scanned text, readable in the full document.

  2. 03

    Page 2 of 13 are reported: 1. Pursuant to Section 71 2. To assist firms insp…

7 more observations

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Endo USA, Inc.?

FDA listed 9 observations on this Form 483, mostly about laboratory controls. The most-cited regulation is 21 CFR 211.160 (general requirements). The opening words of each observation are shown on this page.

Who inspected Endo USA, Inc.?

Ankur C. Patel is named on this Form 483, for the inspection of Jan 7 – Jan 17, 2025. Each investigator has a profile showing what they cite most.

When was Endo USA, Inc. inspected by FDA?

The inspection ran Jan 7 – Jan 17, 2025, and the Form 483 is dated January 17, 2025.

How do I get the full Form 483 for Endo USA, Inc.?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free